BioAge Labs (BIOA) Gross Profit (2024 - 2026)

BioAge Labs has disclosed Gross Profit across 3 years of filings, most recently posting -$14.2 million for Q2 2026.

• In Q2 2026, Gross Profit fell 23.25% year-over-year to -$14.2 million; the TTM figure through Jun 2026 stood at -$50.3 million (down 18.25% YoY), while the FY2025 annual figure was -$40.5 million, down 8.95% from the prior year.
• Gross Profit came in at -$14.2 million for Q2 2026 at BioAge Labs, down from -$10.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of -$3.2 million in Q1 2025 to a low of -$15.5 million in Q4 2025.
• Average Gross Profit over 3 years is -$10.2 million, with a median of -$11.0 million recorded in 2025.
• Year-over-year, Gross Profit jumped 31.08% in 2025 and slumped 226.27% in 2026.
• Over 3 years, Gross Profit stood at -$13.4 million in 2024, then decreased by 16.31% to -$15.5 million in 2025, then increased by 8.44% to -$14.2 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were -$14.2 million in Q2 2026, -$10.4 million in Q1 2026, and -$15.5 million in Q4 2025.